
The future of sweet, savory, and everything in between.
Made by Manus®. At IFT FIRST 2026.
Dive into it all below or experience it all at IFT FIRST 2026 in Chicago, Illinois.
Request a meeting with an expert now or at IFT.
Monk Fruit Sweetener
For the first time ever, monk fruit sweetener is being manufactured at commercial scale in the United States – right here at our biomanufacturing facility in Augusta, Georgia.
We have reimagined a scarce, crop-dependent ingredient into a more reliable, scalable, and sustainable sweetening solution for global food and beverage brands. By moving beyond traditional supply constraints and overseas sourcing, we are helping shape a more resilient – and more delicious – future for sweetness.
At IFT, we will have our Monk Fruit Sweetener available to sample in a variety of snacks and beverages, including:
01
Strawberry Mint Cooler
Get Strawberry Mint Cooler ingredient Card
02
Passion Fruit Tea
Get Passion Fruit Tea Ingredient Card
03
Golden Harvest Muffin
Get Golden Harvest Muffin Ingredient Card

Yume M Stevia Sweetener
Explore also our premium stevia sweetener that forgoes many of the risks associated with traditional stevia agriculture. Without compromising flavor or performance.
Made by Manus®.
Brought to you by Tate & Lyle.
From the first seed to the final ingredient, discover our journey to sweetness made best.
Learn moreEvent
Visit us at booth #437
Highlights
11:15 am – 1:45 pm
Presentation:
Reb M Stevia Without Compromise:
Taste, Performance, and Supply You Can Formulate
Speakers

Frederik Bjoerndal
Manus

Abigail Storms
Tate & Lyle
Visit us at booth #437
Speak to an expert
Book an in-person meeting at IFT FIRST 2026 or an online meeting before or after IFT with Gary Dempsey, Vice President, Global Sales

Manus BioIngredients™
Explore our BioAlternatives to citrus oils produced from lab to full-scale manufacturing through our bioalternatives scale-up platform. They offer consistent, high-quality flavor while reducing reliance on volatile agricultural supply chains.
Newsletter
Get The BioAlternatives Brief
Welcome to The BioAlternatives Brief, built for leaders navigating the shift to bioalternatives by connecting market movement, technical progress, and what it means for everything that comes next.
Get the Brief


